Home › Funds › UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME › TSM

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME position in TSM

TAIWAN SEMICONDUCTOR MANUFAC · Technology

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME reported holding 10,055,901 shares of TSM (TAIWAN SEMICONDUCTOR MANUFAC) in its Q3 2026 13F filing — a position valued at US$4.59B, representing 0.70% of its reported portfolio and ranking #20 among its reported holdings. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed TSM holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)10.06M sh
Reported value held$4.59B
Portfolio Weight0.70%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's TSM position evolved

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME first disclosed a stake in TSM in Q3 2023 at 1,167,995 shares (US$101.5M). The position peaked in Q3 2026 at 10,055,901 shares, worth US$4.59B. Across 12 filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 10,055,901 shares valued at US$4.59B — an increase of 6,023,555 shares quarter over quarter.. Notable position changes include a 799% increase in Q3 2024 (shares rose 14% over the following quarter), a 899% increase in Q1 2026 (shares rose 40% over the following quarter), a 149% increase in Q3 2026 (shares fell 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.17M $101.50M New
Q4 2023 1.20M $125.20M Add
Q1 2024 1.37M $186.39M Add
Q2 2024 211.20K $36.71M Reduce
Q3 2024 1.90M $329.81M Add
Q4 2024 1.59M $313.99M Reduce
Q1 2025 1.92M $318.96M Add
Q2 2025 2.13M $481.98M Add
Q4 2025 410.56K $124.77M New
Q1 2026 4.10M $1.39B Add
Q2 2026 4.03M $1.93B Reduce
Q3 2026 10.06M $4.59B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TSM and 13F data

TSM (TAIWAN SEMICONDUCTOR MANUFAC) is a Technology company. 41 other funds we track also report a position in TSM — the largest reported positions include Fidelity Management & Research (FMR) (US$29.82B), Capital World Investors (US$16.41B), Capital World Investors (US$15.42B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TSM

All TSM fund holders →

FAQ

How long has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME held TSM?

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME has disclosed TSM holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME's current position in TSM?

As of Q3 2026, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME holds 10.06M shares of TSM (TAIWAN SEMICONDUCTOR MANUFAC), valued at $4.59B, representing 0.70% of its reported portfolio and ranking #20.

Has UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME been buying or selling TSM?

In the latest 13F filing (Q3 2026), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME increased its position in TSM. The position peaked in Q3 2026 at 10.06M shares.

Which other funds hold TSM?

Other major institutional holders of TSM include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.